Krett N - Search Results

1

RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells.

Chauhan D, Hideshima T, Pandey P, Treon S, Teoh G, Raje N, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC. Chauhan D, et al. Among authors: krett n. Oncogene. 1999 Nov 18;18(48):6733-40. doi: 10.1038/sj.onc.1203082. Oncogene. 1999. PMID: 10597281

2

Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.

Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC, Anderson KC. Chauhan D, et al. Among authors: krett n. Oncogene. 2002 Feb 21;21(9):1346-58. doi: 10.1038/sj.onc.1205205. Oncogene. 2002. PMID: 11857078

3

Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells.

Chauhan D, Pandey P, Ogata A, Teoh G, Krett N, Halgren R, Rosen S, Kufe D, Kharbanda S, Anderson K. Chauhan D, et al. Among authors: krett n. J Biol Chem. 1997 Nov 28;272(48):29995-7. doi: 10.1074/jbc.272.48.29995. J Biol Chem. 1997. PMID: 9374472 Free article.

4

Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells.

Greenstein S, Krett NL, Kurosawa Y, Ma C, Chauhan D, Hideshima T, Anderson KC, Rosen ST. Greenstein S, et al. Exp Hematol. 2003 Apr;31(4):271-82. doi: 10.1016/s0301-472x(03)00023-7. Exp Hematol. 2003. PMID: 12691914 Free article. Review.

5

8-amino-adenosine is a potential therapeutic agent for multiple myeloma.

Krett NL, Davies KM, Ayres M, Ma C, Nabhan C, Gandhi V, Rosen ST. Krett NL, et al. Mol Cancer Ther. 2004 Nov;3(11):1411-20. Mol Cancer Ther. 2004. PMID: 15542780

6

Association of PKC delta and active Src in PMA-treated MCF-7 human breast cancer cells.

Shanmugam M, Krett NL, Peters CA, Maizels ET, Murad FM, Kawakatsu H, Rosen ST, Hunzicker-Dunn M. Shanmugam M, et al. Among authors: krett nl. Oncogene. 1998 Apr 2;16(13):1649-54. doi: 10.1038/sj.onc.1201684. Oncogene. 1998. PMID: 9582012

7

Caspase activation is required for gemcitabine activity in multiple myeloma cell lines.

Nabhan C, Gajria D, Krett NL, Gandhi V, Ghias K, Rosen ST. Nabhan C, et al. Mol Cancer Ther. 2002 Nov;1(13):1221-7. Mol Cancer Ther. 2002. PMID: 12479703

8

In vitro assessment of nucleoside analogs in multiple myeloma.

Krett NL, Ayres M, Nabhan C, Ma C, Nowak B, Nawrocki S, Rosen ST, Gandhi V. Krett NL, et al. Cancer Chemother Pharmacol. 2004 Aug;54(2):113-21. doi: 10.1007/s00280-004-0777-2. Epub 2004 May 4. Cancer Chemother Pharmacol. 2004. PMID: 15133625

9

8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma.

Ghias K, Ma C, Gandhi V, Platanias LC, Krett NL, Rosen ST. Ghias K, et al. Mol Cancer Ther. 2005 Apr;4(4):569-77. doi: 10.1158/1535-7163.MCT-04-0303. Mol Cancer Ther. 2005. PMID: 15827330

10

Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines.

Rizvi MA, Ghias K, Davies KM, Ma C, Weinberg F, Munshi HG, Krett NL, Rosen ST. Rizvi MA, et al. Mol Cancer Ther. 2006 Jul;5(7):1783-9. doi: 10.1158/1535-7163.MCT-05-0465. Mol Cancer Ther. 2006. PMID: 16891464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters